Kura Oncology Stock Market Value


USD 14.86  0.48  3.13%   

Kura Oncology's market value is the price at which a share of Kura Oncology stock trades on a public exchange. It measures the collective expectations of Kura Oncology investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Kura Oncology and determine expected loss or profit from investing in Kura Oncology over a given investment horizon. Please see Kura Oncology Correlation, Kura Oncology Volatility and Kura Oncology Alpha and Beta module to complement your research on Kura Oncology.

Is Kura Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kura Oncology. If investors know Kura Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kura Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
982 M
Return On Assets
Return On Equity
The market value of Kura Oncology is measured differently than its book value, which is the value of Kura Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Kura Oncology's value that differs from its market value or its book value, called intrinsic value, which is Kura Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kura Oncology's market value can be influenced by many factors that don't directly affect Kura Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kura Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine Kura Oncology value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kura Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Kura Oncology 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kura Oncology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kura Oncology.
No Change 0.00  0.0 
In 30 days
If you would invest  0.00  in Kura Oncology on October 27, 2022 and sell it all today you would earn a total of 0.00 from holding Kura Oncology or generate 0.0% return on investment in Kura Oncology over 30 days. Kura Oncology is related to or competes with Regeneron Pharmaceuticals, and Vertex Pharmaceutic. Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the U... More

Kura Oncology Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kura Oncology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kura Oncology upside and downside potential and time the market with a certain degree of confidence.

Kura Oncology Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Kura Oncology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kura Oncology's standard deviation. In reality, there are many statistical measures that can use Kura Oncology historical prices to predict the future Kura Oncology's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Kura Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Kura Oncology in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
LowNext ValueHigh
5 Analysts
LowTarget PriceHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kura Oncology. Your research has to be compared to or analyzed against Kura Oncology's peers to derive any actionable benefits. When done correctly, Kura Oncology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Kura Oncology.

Kura Oncology Backtested Returns

We consider Kura Oncology not too volatile. Kura Oncology has Sharpe Ratio of 0.0487, which conveys that the firm had 0.0487% of return per unit of risk over the last 3 months. Our standpoint towards estimating the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Kura Oncology, which you can use to evaluate the future volatility of the firm. Please verify Kura Oncology Downside Deviation of 3.45, risk adjusted performance of 0.0084, and Mean Deviation of 2.87 to check out if the risk estimate we provide is consistent with the expected return of 0.19%.
Kura Oncology has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.9666, which conveys possible diversification benefits within a given portfolio. Let's try to break down what Kura Oncology's beta means in this case. Kura Oncology returns are very sensitive to returns on the market. As the market goes up or down, Kura Oncology is expected to follow. Although it is important to respect Kura Oncology price patterns, it is better to be realistic regarding the information on the equity's historical price patterns. The philosophy towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Kura Oncology technical indicators, you can presently evaluate if the expected return of 0.19% will be sustainable into the future. Kura Oncology right now secures a risk of 3.81%. Please verify Kura Oncology semi variance, and the relationship between the maximum drawdown and accumulation distribution to decide if Kura Oncology will be following its current price movements.



Modest predictability

Kura Oncology has modest predictability. Overlapping area represents the amount of predictability between Kura Oncology time series from 27th of October 2022 to 11th of November 2022 and 11th of November 2022 to 26th of November 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kura Oncology price movement. The serial correlation of 0.5 indicates that about 50.0% of current Kura Oncology price fluctuation can be explain by its past prices.
Correlation Coefficient0.5
Spearman Rank Test0.5
Residual Average0.0
Price Variance0.06

Kura Oncology lagged returns against current returns

Autocorrelation, which is Kura Oncology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kura Oncology's stock expected returns. We can calculate the autocorrelation of Kura Oncology returns to help us make a trade decision. For example, suppose you find that Kura Oncology stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
   Current and Lagged Values   

Kura Oncology regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kura Oncology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kura Oncology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kura Oncology stock over time.
   Current vs Lagged Prices   

Kura Oncology Lagged Returns

When evaluating Kura Oncology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kura Oncology stock have on its future price. Kura Oncology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kura Oncology autocorrelation shows the relationship between Kura Oncology stock current value and its past values and can show if there is a momentum factor associated with investing in Kura Oncology.
   Regressed Prices   

Kura Oncology Investors Sentiment

The influence of Kura Oncology's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Kura Oncology. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Kura Oncology's public news can be used to forecast risks associated with investment in Kura Oncology. The trend in average sentiment can be used to explain how an investor holding Kura Oncology can time the market purely based on public headlines and social activities around Kura Oncology. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Kura Oncology's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Kura Oncology's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Kura Oncology's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Kura Oncology.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kura Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kura Oncology's short interest history, or implied volatility extrapolated from Kura Oncology options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Kura Oncology using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Kura Oncology Correlation, Kura Oncology Volatility and Kura Oncology Alpha and Beta module to complement your research on Kura Oncology. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for analysis

When running Kura Oncology price analysis, check to measure Kura Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kura Oncology is operating at the current time. Most of Kura Oncology's value examination focuses on studying past and present price action to predict the probability of Kura Oncology's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kura Oncology's price. Additionally, you may evaluate how the addition of Kura Oncology to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bond Directory
Find actively traded corporate debentures issued by US companies
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Kura Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Kura Oncology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Kura Oncology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...